Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 6—June 2026
Research Letter
Cutibacterium avidum Bacteria in Post-Mastectomy Breast with Prior Silicone Injections, Singapore
Suggested citation for this article
Abstract
We isolated Cutibacterium avidum bacteria from remanant siliconomas noted during left mastectomy with reconstruction and right breast reduction in a 48-year-old woman with prior history of silicon injections. Chronic siliconomas can support anaerobic colonization, posing infection risks relevant to reconstructive and oncologic timelines.
We report a case of Cutibacterium avidum bacteria isolated from breast tissue in a 48-year-old woman with a diagnosis of left breast triple-negative carcinoma and a prior history of breast augmentation by free silicone injections to bilateral breasts. Twenty years before, the patient received multiple series of non–Food and Drug Association-approved silicone injections administered to bilateral breast tissue in all anatomic planes at an unidentified center in a foreign country. She underwent left endoscopic nipple-sparing mastectomy with pedicled transverse rectus abdominis myocutaneous flap reconstruction and contralateral reduction mammoplasty with free nipple graft. Prior research from our institution details those reconstructive techniques (1,2). Intraoperatively, we discovered multiple loculated lesions of varied size and consistency during dissection, confirming a diagnosis of siliconomas (Figure). Because of the extensive presence of lesions in both breasts, we sent tissue from the siliconomas for histopathology and conducted culture analysis, including Gram stain, aerobic, anaerobic, acid-fast bacilli, and fungal cultures, which confirmed the unusual presence of C. avidum bacteria. We then consulted an infectious disease specialist and, thereafter, placed the patient on a regimen of oral clindamycin 300 mg twice daily for 10 days as per standard sensitivity reports. While on that antibiotic regimen, the patient recovered without any complications.
Cutibacterium species (particularly C. acnes) are well recognized in breast implant infections and capsular contracture, however, our case demonstrated the colonization of this bacterial species in free silicon injection. C. avidum following reduction mammoplasty has been reported (3), and more recently has been reported in cosmetic breast implant augmentation, where the bacterium displayed true pathogenic behavior rather than acting as simply a contaminant (4). Other reports investigating infections relevant to aesthetic surgery have emphasized the pathogen’s association with foreign material and surgical manipulation, underscoring that C. avidum cannot be dismissed as a benign commensal (5,6).
Chronic siliconomas emerge as a result of a long-standing foreign-body environment. Our case suggests that siliconomas might harbor anaerobic pathogens similar to those harbored by implants or prostheses. Our findings are novel in that they suggest an extension of the clinical spectrum of C. avidum bacteria to silicone-injected breasts, a scenario distinct from conventional implant-based infections. Infection is an independent risk factor for flap failure (7,8), and contributes to delayed healing, flap compromise, and partial or total necrosis. Even low-grade infection can increase the risk for flap failure through inflammatory microthrombosis and impaired perfusion. Expedited healing is important in patients undergoing breast reconstruction to facilitate adjuvant chemotherapy or radiotherapy and improve overall survival (9). Therefore, C. avidum bacteria isolated from an operative field with established pathogenic potential in implant-associated infections should be regarded with appropriate diligence and treated irrespective of the clinical symptoms.
We highlight this case to alert surgeons that C. avidum bacteria is clinically relevant in patients with silicone injections or foreign material in breast tissue, especially as they maneuver through the course of concomitant reconstructive procedures. Awareness may influence interpretation of intraoperative cultures, antimicrobial selection, and management of late or indolent infections in this unique subgroup. In the setting of a free flap reconstruction, it is prudent to treat C. avidum formally with a course of antimicrobial drugs rather than risk an infection-related flap death.
Dr. Subramanian is a plastic, reconstructive and aesthetic surgeon, currently pursuing an advanced microsurgery fellowship at Sengkang General Hospital, Singapore. Her fields of interest include breast, lower limb, and lymphatic reconstruction, plastic surgery education, and research.
References
- Wong AWJ, Kuo WL, Cheong DCF, Tsai HP, Kao SW, Chen CF, et al. Six steps for a successful aesthetic free flap reconstruction after minimally invasive mastectomy: a retrospective case-control study. Int J Surg. 2024;110:645–53. DOIPubMedGoogle Scholar
- Tan TJK, Wong AWJ, Chua HW. Traction-assisted chest elevation (TRACE)—a novel technique for improving intraoperative ergonomics in endoscopic mastectomy. J Surg Case Rep. 2025;2025:
rjaf321 . DOIPubMedGoogle Scholar - Panagea S, Corkill JE, Hershman MJ, Parry CM. Breast abscess caused by Propionibacterium avidum following breast reduction surgery: case report and review of the literature. J Infect. 2005;51:e253–5. DOIPubMedGoogle Scholar
- Isabel R, Monica M. Cutibacterium avidum: a rare but expected agent of breast implant infection. IDCases. 2019;17:
e00546 . DOIPubMedGoogle Scholar - Ray A, Zaremba S, Baldwin L. Cutibacterium avidum: a unique skin flora infection without foreign body in mastopexy. Am J Cosmet Surg. 2024;41:30–3.
- Isabel Cristina RS, Diego P-R. Cutibacterium avidum: a virulent pathogen in esthetic surgery infection, a case series. Anaerobe. 2025;92:
102944 . DOIPubMedGoogle Scholar - Ouyang SB, Wu ZH, Zhang YP, Lu XL. Comprehensive analysis of risk factors for flap necrosis in free flap reconstruction of postoperative tissue defects in oral and maxillofacial tumors. Sci Rep. 2024;14:18676. DOIPubMedGoogle Scholar
- Las DE, de Jong T, Zuidam JM, Verweij NM, Hovius SE, Mureau MA. Identification of independent risk factors for flap failure: a retrospective analysis of 1530 free flaps for breast, head and neck and extremity reconstruction. J Plast Reconstr Aesthet Surg. 2016;69:894–906. DOIPubMedGoogle Scholar
- Lanthaler M, Spechtler K, Krapf J, Egle D, Sieb M, Tasch C, et al. Does the breast reconstruction method have an impact on time delay to adjuvant chemotherapy – a comparison between autologous and expander/implant breast reconstruction. JPRAS Open. 2022;33:131–8. DOIPubMedGoogle Scholar
Figure
Suggested citation for this article: Subramanian S, Chung De Wei I, Wen CH, Wei-Jiat Wong A. Cutibacterium avidum bacteria in post-mastectomy breast with prior silicone injections, Singapore. Emerg Infect Dis. 2026 Jun [date cited]. https://doi.org/10.3201/eid3206.251717
Original Publication Date: May 27, 2026
Table of Contents – Volume 32, Number 6—June 2026
| EID Search Options |
|---|
|
|
|
|
|
|

Please use the form below to submit correspondence to the authors or contact them at the following address:
Allen Wei-Jiat Wong, Sengkang General Hospital, Sengkang East Way, Singapore 544886
Top